Facial Harmonization with Fillers and Botulinum Toxin
Evidence and Clinical Limits
Keywords:
Facial harmonization, Dermal fillers, Botulinum toxinAbstract
Facial harmonization is an important strategy for aesthetics. Among the available resources, dermal fillers and botulinum toxin stand out, and when used in combination, they enhance results by reducing the mechanical degradation of hyaluronic acid, leading to more beneficial outcomes. Thus, with the aim of investigating the evidence and therapeutic limitations of the combined use of these compounds, an integrative literature review was conducted between 2016 and 2024 in the PubMed and SciELO databases. The results demonstrated efficacy, especially in the upper third of the face, as well as applications in aesthetic dentistry. Regarding safety, the main adverse effects reported were erythema, edema, ecchymosis, and nodules. It is concluded that facial harmonization with botulinum toxin and dermal fillers is effective and relatively safe when performed by qualified professionals. Considering clinical limitations, the consolidation of evidence-based protocols requires greater reporting and dissemination of complications.
References
Carruthers JDA, et al. Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations. Plast Reconstr Surg. 2008 May;121(5 Suppl):5S-30S. doi: 10.1097/PRS.0b013e31816de8d0. PMID: 18449026. Disponível em: https://pubmed.ncbi.nlm.nih.gov/18449026/. Acesso em: 23 jul. 2025.
Sundaram H, et al. Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations. Plast Reconstr Surg. 2016 May;137(5):1410-23. doi: 10.1097/PRS.0000000000002119. PMID: 27119917; PMCID: PMC5242215. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC5242215/. Acesso em: 23 jul. 2025.
Nestor MS, et al. The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II. J Cosmet Dermatol. 2020 Nov;19(11):2785-804. doi: 10.1111/jocd.13702. Epub 2020 Sep 16. Erratum in: J Cosmet Dermatol. 2021 Jun;20(6):1954. doi: 10.1111/jocd.14108. PMID: 32866999; PMCID: PMC7693297. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC7693297/. Acesso em: 23 jul. 2025.
Oranges CM, et al. Universal and ethnic-specific considerations on facial rejuvenation: where do you inject your fillers? Plast Reconstr Surg Glob Open. 2016 Aug 12;4(8):e842. doi: 10.1097/GOX.0000000000001010. PMID: 27622110; PMCID: PMC5010333. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC5010333/. Acesso em: 23 jul. 2025.
Di Santis ÉP, et al. Adverse effects of the aesthetic use of botulinum toxin and dermal fillers on the face: a narrative review. An Bras Dermatol. 2025 Jan-Feb;100(1):87-103. doi: 10.1016/j.abd.2024.04.007. Epub 2024 Nov 29. PMID: 39616095; PMCID: PMC11745296. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC11745296/. Acesso em: 23 jul. 2025.
Maci M, Fanelli C, Lorusso M, Ferrara D, Caroprese M, Laurenziello M, Tepedino M, Ciavarella D. Botulinum toxin type A and hyaluronic acid dermal fillers in dentistry: a systematic review of clinical application and indications. J Clin Med Res. 2024 Jun;16(6):273-83. doi: 10.14740/jocmr5202. Epub 2024 Jun 30. PMID: 39027812; PMCID: PMC11254312. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC11254312/. Acesso em: 23 jul. 2025.
Goodman GJ, et al. Facial aesthetic injections in clinical practice: pretreatment and posttreatment consensus recommendations to minimise adverse outcomes. Australas J Dermatol. 2020 Aug;61(3):217-25. doi: 10.1111/ajd.13273. Epub 2020 Mar 22. PMID: 32201935; PMCID: PMC7497045. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC7497045/. Acesso em: 23 jul. 2025.
de Queiroz Hernandez PM, et al. Evaluation of the attractiveness of lips with different volumes after filling with hyaluronic acid. Sci Rep. 2023 Mar 21;13(1):4589. doi: 10.1038/s41598-023-31332-1. PMID: 36944639; PMCID: PMC10030776. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC10030776/. Acesso em: 23 jul. 2025.
Papagni M, et al. The esthetic use of botulinum toxins in cancer patients: providing a foundation for future indications. Toxins (Basel). 2025 Jan 10;17(1):31. doi: 10.3390/toxins17010031. PMID: 39852984; PMCID: PMC11769536. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC11769536/. Acesso em: 23 jul. 2025.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista de Divulgação Científica Sena Aires
This work is licensed under a Creative Commons Attribution 4.0 International License.
-
Atribuição — Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.
